January 14, 2022

CfA Files SEC Complaint Against Natera Inc. for Misleading Investors

Today, Campaign for Accountability filed a complaint with the Securities and Exchange Commission requesting an investigation into Natera Inc., a clinical genetic testing company. Following New York Times reporting on the company’s prenatal tests, CfA alleges that Natera appears to have misled investors about the accuracy of its prenatal genetic tests and failed to disclose the investor risk associated with tests resulting in false positives.

Latest Work

Jan 14, 2022

Watchdog Files SEC Complaint Against Natera Inc. for Misleading Investors

Jan 4, 2022

TTP Investigation: Militia Content Still Thriving on Facebook a Year After Capitol Riot

Dec 15, 2021

TTP Director Katie Paul Named as One of Newsweek’s 50 Greatest Disruptors

Dec 8, 2021

Watchdogs Sue FEC for Failure to Investigate Coordination between the Russian Government and President Trump’s 2016 Campaign

Dec 8, 2021

TTP Investigation: Instagram’s Algorithm Fuels Eating Disorder Epidemic

Dec 7, 2021

TTP Investigation: Instagram Offers Drug Pipeline to Kids

Oct 24, 2021

TTP Investigation: YouTube’s Filter Bubble Problem is Worse for Fox News Viewers

Oct 5, 2021

TTP Research Featured in Senate Facebook Whistleblower Hearing

Oct 1, 2021

TTP Investigation: Facebook’s Continued Failure on Harmful Teen Ads Contradicts Senate Testimony
Get the latest news and actions

Sign up for updates